HR+/HER2- Ductal and Lobular Breast Cancer

Explore clinical trials studying HR+/HER2- Ductal and Lobular Breast Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

HR+/HER2- Ductal and Lobular Breast Cancer trial results

Recruiting

NCT06562192

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +26 more
Locations: Uni of Alabama at Birmingham Birmingham, Alabama, United States

University of California LA Los Angeles, California, United States

Stanford University Medical Center Palo Alto, California, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

View all 29 locations

Recruiting

NCT07261631

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +30 more
Locations: Novartis Investigative Site Montreal, Quebec, Canada

Novartis Investigative Site Odense C, Denmark

Novartis Investigative Site Vandœuvre-lès-Nancy, France

Novartis Investigative Site Essen, Germany